Abstract
Background
Anastomotic leakage represents a major complication following resections in colorectal surgery. Among others, intestinal inflammation such as in inflammatory bowel disease is a significant risk factor for disturbed anastomotic healing. Despite technical advancements and several decades of focused research, the underlying mechanisms remain incompletely understood. Animal experiments will remain the backbone of this research in the near future. Here, instructions on a standardized and reproducible murine model of preoperative colitis and colorectal anastomosis formation are provided to amplify research on anastomotic healing during inflammatory disease.
Methods
We demonstrate the combination of experimental colitis and colorectal anastomosis formation in a mouse model. The model allows for monitoring of anastomotic healing during inflammatory disease through functional outcomes, clinical scores, and endoscopy and histopathological examination, as well as molecular analysis.
Discussion
Postoperative weight loss is used as a parameter to monitor general recovery. Functional stability can be measured by recording bursting pressure and location. Anastomotic healing can be evaluated macroscopically from the luminal side by endoscopic scoring and from the extraluminal side by assessing adhesion and abscess formation or presence of dehiscence. Histologic examination allows for detailed evaluation of the healing process.
Conclusion
The murine model presented in this paper combines adjustable levels of experimental colitis with a standardized method for colorectal anastomosis formation. Extensive options for sample analysis and evaluation of clinical outcomes allow for detailed research of the mechanisms behind defective anastomotic healing.
Supplementary information
The online version contains supplementary material available at 10.1007/s00384-021-04014-5.
Keywords: Anastomotic leakage, Insufficient healing, Dextran sodium sulfate
Introduction
Delayed or insufficient healing at the site of a colorectal anastomosis can lead to anastomotic leakage (AL) with the respective morbidity. With worldwide incidence rates of 1–24% [1–6], it is a frequent and serious complication leading to intraabdominal septic conditions and even death. A wide variety of animals (ranging from mice and rats to dogs and pigs) are used, and a large number of risk-factors and therapeutic approaches for AL have been examined [7].
Although the discussion around the most appropriate surgical technique is still ongoing [8–11], it is well accepted that precise adaption of the tissue, especially the serosa, is an indispensable requirement for anastomotic healing. However, even in case of a technically flawless anastomosis formation, several risk factors remain a threat to the healing process by influencing the immune response or tissue perfusion. Even in case of a technically flawless anastomosis, several risk factors are threatening the healing process by influence on the immune response or perfusion. The underlying (patho-)physiology of anastomotic healing consists of an inflammatory, a proliferative, and a regenerative phase [12, 13]. Transition between these phases is smooth, and it is important to see them as part of one intricate, orchestrated continuum. Overwhelming inflammation such as in inflammatory bowel disease (IBD) hampers the anastomotic tissue from proceeding to the later phases of wound healing [14]. The dilemma in treatment of patients with inflammatory bowel diseases (IBD) is that they are prone to operations while at the same time requiring immunosuppressive medication. This corroborates the call for development of further treatment strategies in this high-risk cohort.
A vast amount of approaches has been evaluated. However, despite several decades of focused research, no clinically approved therapy to markedly reduce the incidence of AL has been translated into clinical routine yet [15].
This only highlights the need for dedicated research in order to fill the gaps in our knowledge of how the complex gastrointestinal healing processes work – and how AL especially in chronic inflammatory conditions – can be treated or even prevented altogether. To this date, pre-clinical research on anastomotic healing and colitis is often poor in quantity and quality of reporting [7]. Hence, the aim of this project is to demonstrate a standardized, reproducible, and easy-to-learn murine model combining experimental colitis with colorectal anastomosis formation and to present several scores to analyze anastomotic healing on a functional, macro-, and microscopic and molecular level. This should contribute to more standardized and therefore better quality research in the future.
Methods
In the following, a brief and concise description of the experimental setup will be outlined. For more detailed and complete information, we refer to the supplemental material.
Compliance with regulations for animal experiments statement
All procedures that are performed on animals should be conducted under specific pathogen-free (SPF) conditions as defined by FELASA and must be approved after legal and ethical review by the local animal welfare committee of the performing institution.
Animal experiments
It is recommended to use adult female mice at an age of 10–12 weeks and with an average weight of 20 g. Although the use of only one sex in an animal experiment is usually discouraged, females, unlike the more aggressive males, can be co-housed. This facilitates equalization of commensal gut microbiota and thus helps to standardize the experimental conditions. It is important to closely monitor the mice clinically for weight loss and to assess pain and distress daily. Before the start of the experiments, mice which are not bred in-house need a standardized acclimatization phase to adapt to the local microbiota of animal housing and eliminate confounding factors like stress associated with shipping. At least 7 days are recommended for this phase, but duration can be adapted to local conditions. If possible, use co-housing to improve exchange of commensal bacteria and include the same acclimatization phase in the protocol for control groups to ensure comparable results.
Colitis induction
In the following, two different methods for induction of chemically induced colitis in mice will be described.
For dextran sodium sulfate (DSS) colitis (Fig. 1e), we refer to the established protocols [16]. In brief, DSS is dissolved in standard drinking water to a set percentage depending on the acquired intensity of inflammation (see below). This water is then offered ad libitum for several days to induce colitis. In terms of the timeframe and dose for induction, it is best to aim for mild colitis (target disease activity index (DAI) [16] of 1–2), in order to ensure an inflamed, but not completely ulcerated mucosa. This prevents excessive weight loss, high disease activity, and high strain on the animals. We recommend to start with colitis induction 7 days preoperatively. After surgery, mice are offered normal water. It is important to note that the dose of DSS varies widely depending on environmental factors.
To induce 2,4,6-trinitro benzene sulfonic acid (TNBS) colitis (Fig. 1e), we adapted the protocol by Wirtz et al. [16]. Pre-sensitization is performed 7 days prior to surgery under inhalational anesthetic (e.g., isoflurane). A 1 × 1 cm patch of skin is shaved on the back of the mouse, and the freshly mixed pre-sensitization solution is applied. We adapted the protocol using only 30 µl of pre-sensitization solution to allow for complete absorption. It is important to make sure the same amount of fluid is used on every individual animal.
After the 7 days of pre-sensitization, TNBS colitis is induced by rectal application of the induction solution. To do so, gently advance a 3.5 F catheter into the colon until a soft resistance (the colonic flexure) can be felt, making sure not to damage the colon in the process. Slowly inject 50 µl of the solution and hold the mouse head down for 1 min. The effect of TNBS colitis depends on the mouse strain; the microbiotic and genetic factors and therefore disease activity can vary. Adapt the dosage of TNBS for weight loss of less than 5% on the day after induction. It is recommended to abort the experiment for an individual animal if this limit is exceeded.
In both models, colonoscopy can be used to assess presence of inflammation and verify integrity of the colon after inducing colitis before proceeding to surgery.
Anesthesia and analgesia
It is recommended to use inhalational (e.g., isoflurane) over injectable anesthetics (e.g., medetomidine, midazolam, and fentanyl) to prevent loss of its effects during the procedure. Although initial induction by intraperitoneal anesthesia is imaginable, it is not safely possible to boost anesthesia intraoperatively or antagonize postoperatively.
Since isoflurane does not provide an analgesic effect sufficient for surgical tolerance, additional analgesics must be administered. In total, 1 mg/kg of metacam s.c. and 0.1 mg/kg buprenorphine s.c. about 20 min prior to isoflurane application should be administered. Administer an additional dose of 0.1 mg/kg buprenorphine s.c. about 6 h after surgery and 1 mg/kg of metacam s.c. each on the first and second postoperative day. Note, however, that NSAIDs like metacam can interfere with inflammatory components of the model and opioids like buprenorphine decrease bowel motility.
Induce general anesthesia for colonoscopy, surgery, and euthanasia. Apply eye ointment to protect the cornea. Avoid hypothermia by using an adjustable heating pad.
Colonoscopy
Place the anesthetized mouse prone onto a heated pad; limbs may be fixated with tape. Insert a murine endoscope (e.g., Image 1 HD SCB 22,201,020 hub, Xenon 175 20,132,120 light source, H3-Z 22,220,055 camera head, HOPKINS® 64,301 AA straightforward telescope 0° and 61,029 C trocar, all by KARL STORZ & Co. KG., Fig. 2c) under careful insufflation to minimize trauma to the anus, while keeping the tail in one hand (Fig. 2d). Lubrication might be used to facilitate this process.
Endoscopy can be performed using either air or 0.9% sodium chlorine solution for insufflation. Sodium chlorine solution allows for gentler insufflation and a very even distribution of pressure along the colon, whereas the air as a medium allows for clearer images (see Fig. 2a, b, e–h). To evaluate the anastomosis, advance the endoscope up to the colic flexure, and then start recording a video while pulling back steadily until exiting the colon for standardized documentation. Gently rotate the endoscope at the site of anastomosis to get a good visual of the entire perimeter of the wound.
Colorectal anastomosis formation
In the following, vessel sparing anastomosis formation without bowel resection is described to minimize the potential influence of ischemia on the healing process. In brief, place mouse in supine position, access the colorectum via median laparotomy and blunt preparation technique, and transect the colon between two vasa recta while taking great care not to injure the mesenterial artery (Fig. 1a, b). This vessel along with its branches must be spared to preserve blood supply to the colon and avoid confounding the experiment with ischemic components of anastomotic leakage. Reconnect the colonic stumps in an end-to-end fashion and adapt the suturing technique to the requirements of the experiment. More stitches and running sutures provide tighter approximation of the anastomotic region. To get a higher rate of AL, the total number of stitches can be reduced to eight or even less, while twelve single sutures usually guarantee a very low leakage rate (see Fig. 1c, d for an example with twelve single stitches). Monofilamentous, resorbable polyglactin or polydioxanone sutures are used in humans and can be recommended for this surgical model, also. In proportion with the suture diameter used in human patients, 11–0 would be the analogue suture size in the murine intestine, but this suture is expensive and difficult to handle due to its small size. A 9–0 suture represents a good trade-off between size, price, and handling. Note that this model per se constitutes one of defect healing due to the fact that the mucosa is everted because it is technically almost impossible to attach the serosa layers (Fig. 1f).
Postoperative management
Score mice daily after surgery. We recommend a scoring protocol including the criteria listed in Table 1. We have defined an algorithm for therapeutic measures as well as clear abort criteria based on this score: a total score of 3 requires substitution of i.p. fluid and analgesia; we have aborted the experiment at a total of 8 score points or any single score of 4 or above. Pay special attention to proper healing of the skin suture; revise the suture under general anesthesia if necessary. To improve postoperative weight recovery, oatmeal soaked with glucose solution can be added to the diet. During the early postoperative phase, therapeutic measures, like analgesic treatment by s.c. injection of 1 mg/kg metacam, water soaked food, hydrogel, and substitution of fluid by s.c. injection of 0.9% sodium chloride solution, may be applied.
Table 1.
Criteria | Score points |
---|---|
Weight | 0 = no reduction |
1 = reduction of 0–5% | |
2 = reduction of 6–10% | |
3 = reduction of 11–19% | |
4 = reduction of > 19% | |
Fur | 0 = normal, shiny, smooth |
1 = piloerection | |
Behavior | 0 = normal |
1 = subdued, no exploration, reduced interaction | |
4 = apathy, isolation, stereotypic behavior | |
Posture | 0 = normal |
2 = intermittent cowering or shivering | |
4 = permanent cowering or shivering | |
Pain | 0 = no indication |
2 = defensive behavior on palpation of abdomen | |
Impaired wound healing | 0 = no indication |
2 = red or oozing wound | |
4 = dehiscent suture or ruptured abdomen | |
Dehydration | 0 = skin folds straighten within 2 s |
1 = persistent skin folds | |
Mucous membranes (ears, skin, extremities) | 0 = rosy |
1 = pale | |
Stool | 0 = formed |
1 = diarrhea |
Evaluation of anastomotic healing
Depending on the experimental setup and on the scope of the experiment, different days might be considered for evaluation for the healing process. It is useful to evaluate mice on postoperative day 3 (POD3) for early healing and POD7 and POD14 for late healing. Perform in vivo colonoscopy in the anesthetized animal to score endoscopic healing (Fig. 2a, b, e–h). Sacrifice the mouse, perform longitudinal laparotomy, and grade adhesions and abscess formation by mobilizing the anastomosis and bluntly removing adhesions wherever possible without compromising the integrity of the anastomosis. Extract the colon containing the anastomosis from rectum to the right colic flexure, and gently clear it of feces with a cotton swab.
Bursting pressure measurement
To measure bursting pressure, mount the extracted large intestine onto a petri dish, and insert a plastic cannula into the aboral lumen and an ICP pressure probe (e.g., Omnibar E5F probe and MPR Datalogger, Raumedic AG) into the oral lumen, and fixate with polyfilamentous 4–0 ligatures. After calibrating the pressure in the colon to 0 mmHg, fill it with isotonic saline solution using a syringe attached to the cannula until rapid pressure drop while constantly measuring the intraluminal pressure. Record the maximum of the pressure spike as bursting pressure. Additionally, document the bursting location, differentiating between bursting location at anastomosis or not at anastomosis. This technique provides an easily measurable parameter of mechanical stability independent of microscopic healing.
Collection and preparation of biological samples
There are multiple options to collect and analyze tissue samples. Feces can be retrieved for microbiological analysis. To collect tissue samples, the colon should be placed on a petri dish and dissected lengthwise along the mesocolon. Then, the flattened colon can be dissected lengthwise again with a 22-blade scalpel. We recommend using one-half for biochemical analysis of the tissue, the other half for histology. Use a biopsy punch to retrieve samples from different regions of the colon. For histology, flatten the other half of the colon on the petri dish. To prevent it from coiling up, pipette tissue fixative directly onto the tissue. After a few minutes, place colon into a tube; store tube horizontally until dehydration and embedding. Refer to Fig. 3 for an illustration on sample preparation.
Applicable scores
Endoscopic score
To quantify anastomotic dehiscence and evaluate healing through colonoscopy, we have defined a score ranging from 0 to 4.
See Table 2 for the score and Fig. 2a, b for demonstration of the application of this score. We propose to use this score to assess macroscopic mucosal healing and gross morphology of the anastomosis in vivo. In addition, the degree of dehiscence can also be measured and quantified [17], and if applicable, fluorescent endoscopy can be used for evaluation of different markers of the healing process.
Table 2.
Score points | Criteria |
---|---|
0 | No dehiscence |
1 | Suture thread protruding into lumen |
2 | Slight dehiscence, necrotic tissue, or fibrin on less than a quarter of circumference |
3 | Advanced dehiscence, necrotic tissue, or fibrin on more than a quarter of circumference |
4 | Full dehiscence, visible hole into the peritoneal cavity |
Histological score
Histological scoring of the anastomosis is one of the most objective and exact measures to evaluate the healing process. Here, performance of the microscopic sections and correct alignment of the anastomosis are pivotal. For the scoring of the healing process, Table 3 gives details about allocation of score points, and Fig. 4 demonstrates the application of this score. We recommend using this score in every experiment concerned with anastomotic healing, since it quantifies microstructural and cellular progress of healing and thus reflects the most accurate status of healing at the point of evaluation.
Table 3.
Criteria | Score points (maximum = 29) |
---|---|
Blood vessel ingrowth |
0 = no evidence 1 = occasional evidence 2 = light scattering 3 = abundant evidence 4 = confluent cells or fibers |
Fibroblasts |
0 = no evidence 1 = occasional evidence 2 = light scattering 3 = abundant evidence 4 = confluent cells or fibers |
Collagen formation |
0 = no evidence 1 = occasional evidence 2 = light scattering 3 = abundant evidence 4 = confluent cells or fibers |
Inflammatory cells |
0 = confluent cells or fibers 1 = abundant evidence 2 = light scattering 3 = occasional evidence 4 = no evidence |
First layer in which continuity has been restored (counted from the mucosa outwards towards serosa) |
0 = no layer restored 1 = serosa 2 = muscularis 3 = submucosa 4 = mucosa |
Number of healed layers |
0 – 4 (none, mucosa, submucosa, serosa) |
Epithelium closed |
0 = no 1 = yes |
Crypt architecture restored |
0 = no 1 = yes |
Overall healing quality |
1 = bad 2 = normal 3 = good |
Macroscopic assessment of the anastomosis
To classify the macroscopic aspects of anastomotic healing, combine the adhesion score with a classification of abscess formation.
The adhesion score awards 0 to 7 points for adhesions; higher scores reflect a higher amount of adhesions (see Table 4 for details and Fig. 5a to d for a demonstration of how this score is applied).
Table 4.
Criteria | Score points (maximum = 7) |
---|---|
Are uterus, small intestine or omentum attached to the anastomosis? | 1 point per adherent organ |
Is any other organ attached to the anastomosis? |
0 = no 1 = yes |
Feasibility of removing the adhesions bluntly with a swab |
0 = no adhesions in the first place 1 = all adhesions can be removed bluntly 2 = only part of the adhesions can be removed bluntly 3 = no adhesions can be removed bluntly at all |
In addition, the abscess formation is scored in analogy to the clinical subclasses of stage II diverticulitis in the classification of diverticular disease – an established approach in clinical practice – by appending a letter a to c to the adhesion score (see Table 5 for details).
Table 5.
Classification | Criteria |
---|---|
A | No macroscopically visible abscess formation (note that this does not preclude micro-abscesses visible in histopathological examination of the tissue) |
B | Limited, macroscopically visible abscess (“macro-abscess” for short) |
C | Disseminated peritonitis and/or free anastomotic leakage and/or intestinal perforation |
Discussion
Combining models for colitis and colorectal surgery
We demonstrate our combination model of experimental colitis and colorectal surgery as a feasible and adaptable setup for analysis of anastomotic healing during inflammatory conditions. Furthermore, we report standardized retrieval of biological samples and scores that describe the healing process.
Although historically most of the studies on anastomotic healing have been performed in rats and dogs [7], the intraabdominal intestinal immune response in mice is more comparable to that of humans [18]. Furthermore, mice are cheaper and easier to handle, and the wide variety of available knockout genotypes in mice offers the possibility to research the influence of an immense number of factors on anastomotic healing. Male mice lack the confounding influence of cycle-dependent sex hormones, whereas female mice allow for improved exchange of commensal bacteria through co-housing which is often not an option with the more aggressive males. The surgical approach has been designed to exclude ischemia as a confounding factor in development of anastomotic leakage by sparing all vessels, as research on anastomotic perfusion is not the aim of this model. In short, the model presented here enables researchers to isolate the effect of healing adverse processes like mucosal inflammation on intestinal surgery.
Clinical examination
Weight loss can be used as a surrogate parameter for postoperative recovery. It is especially helpful in evaluating the systemic effect of colitis on the anastomotic healing process. The control groups (See Fig. 6a, d) which have undergone surgery without any colitis present show a characteristic, constant weight loss of up to 15% of their initial weight. They reach the nadir at POD3 after which they start to slowly recover. In combination with perioperative DSS colitis, we have observed weight loss to be more severe and start preoperatively, whereas TNBS colitis does not seem to affect the weight as DSS colitis (see Fig. 6a, d). However, it is only a rough health indicator for an individual. For example, excessive weight loss in an animal may be attributed to reduced food and water intake caused by postoperative pain, colitis, and intestinal paralysis due to analgesics or surgery. If, however, these factors are taken into account and weight loss is considered in combination with other markers of the healing process such as bursting pressure measurements, endoscopy, and macroscopic and microscopic assessment of the anastomosis, it provides an easily measurable parameter which can be very useful for quick orientation on the mouse’s health.
Bursting pressure measurement
The rationale behind bursting pressure measurements is the aim to functionally characterize the stability of the anastomosis. The measurements can give an impression on the stability as well as the completeness of the healing process. The fluid instillation will reveal anastomoses prone to leakage or those that have insufficient healing. However, the measurements can easily yield false values: until the anastomosis has gained back enough tensile strength, success of the healing process is entirely dependent on the mechanical apposition by suture [14] or staples – this is the case during the first 3 to 5 days after surgery [19] due to the high collagenase activity resulting in a reduction of strength of up to 70% within the first 48h [8]. That means, this method will mostly reflect mechanical stability of the sutures instead of the progress of healing, and the suturing technique may mask severe healing defects. Additionally, the relevance of non-physiological bursting pressures of, e.g., more than 100 mmHg or bursting sites in places other than the anastomosis itself (especially in the early healing stages) remains questionable, as intraluminal pressure is usually low. They might be a better indicator for high mechanical stability of the sutures rather than reflect the state of the healing process. Furthermore, the lumen at the anastomotic site is often constricted, therefore reducing its radius. This might interfere with the comparability of bursting pressures recorded at the anastomosis and not at the anastomosis, thus further undermining the relevance of bursting pressure measurements. We therefore caution against using this method as a sole determinant of healing and recommend taking into account whether the bursting occurs directly at the anastomosis or in another region of the intestine. For bursting directly at the site of anastomosis, we recommend considering only pressures which are lower than physiological intraluminal pressure.
Endoscopy scoring
Endoscopy is already widely established for diagnosis and treatment of anastomotic leakage in human patients. It is an easy method to measure macroscopic healing from the luminal side. If available, additional fluorescence endoscopy of labeled markers can be used to assess inflammation in the anastomotic tissue [17]. We recommend using this score in any experiment on anastomotic healing because of the high relevance of endoscopy in clinical practice. The scoring system presented here reduces the complexity of potential findings during endoscopy to a standardized, simple score which could be shown to be a valid parameter for the healing process (see below).
Histological score
In order to get a measure of the microstructural and cellular changes, we have modified the established scoring system proposed by Phillips et al. [20]. The original score focuses on the presence of inflammatory cells and fibroblasts, progress of collagen formation, and ingrowth of blood vessels. On a molecular level, collagen deposition has been viewed as one of the most reliable criteria for measurement of the process of anastomotic healing [21]. We have added some criteria which consider the tremendous relevance of structural integrity and mechanical stability for healing. Namely factoring in a count of the layers that have completely healed, the first layer in which continuity has been restored, whether the epithelium has completely sealed the defect, and whether crypt architecture has been restored. This accounts for the importance of healing on a microscopic and cellular level and objectivizes these findings. We recommend using this adapted score, because it can serve as an excellent primary outcome to evaluate quality of healing.
Macroscopic assessment of the anastomosis
We have developed a combined adhesion and abscess score for standardized reporting of macroscopic aspects of anastomotic healing. This dual scoring system allows to record descriptive data on the conditions within the peritoneal cavity upon evaluation.
However, the limitations of this score must be considered. The mechanisms of adhesion formation and the role of adhesions in intestinal healing are still huge fields of research with many unknowns. Lacking a proven causal relation between adhesion formation and anastomotic healing, the combined adhesion score is not suitable as a surrogate parameter for healing or as a parameter to validate other findings against.
However, it can be used as a means of taking standardized notes of the conditions found upon dissection of the euthanized mouse. Keeping data in this form could be very useful as the basis of research projects which examine the role of adhesions and abscess formation in the context of anastomotic healing.
Expected results
To validate our model, we here present data from an experiment comparing severe DSS colitis, mild TNBS colitis, and a control group without colitis as preoperatively evaluated by DAI (Fig. 6b). The endoscopic healing score on POD3 correlated with preoperative colitis severity (Fig. 6c). There is no significant difference in the weight curves postoperatively comparing the control and TNBS group; however, with severe DSS colitis, postoperative weight loss was significantly higher compared to the control group (Fig. 6a, d). For exemplary data using the histological score, we refer to our previously published study reporting on the use of Ac2-26 coated nanoparticles improving anastomotic healing in a DSS colitis model [22]. In our experiments, both the DSS and TNBS model did not produce significant differences in adhesion formation between the experimental and control groups on any POD.
The abscess classification on the other hand did show a significant difference between the different models of experimental colitis (see Fig. 6e, f). The TNBS and control groups did not show any abscess formation at POD3 or POD7. The DSS group, however, exhibited a significantly higher occurrence of abscess formation on POD3, whereas on POD7, there was no more difference between the groups.
In summary, this data suggests that DSS colitis impairs especially the early healing phase through a more systemic inflammation, whereas TNBS colitis disrupts anastomotic healing more locally and produces less leakage. Depending on the desired effect, either of these models can be chosen.
Conclusion
In summary, DSS and TNBS colitis are widely used models of experimental colitis and can be well combined with surgery, as they lead to timed and reproducible severity of inflammation. Different techniques of anastomoses can be used, depending on the intended scope of research (leakage or sufficient healing model). Different scores aim to improve the quality of reporting by standardizing results and thus reduction and refinement of animal experiments. The bursting pressure as an established functional outcome has to be questioned, whereas an endoscopic score to assess healing from the luminal side of the colon in vivo via murine colonoscopy valuable measures of luminal healing. A refined version of the histological score to assess microscopic healing can be used to examine cellular components of healing and microstructural progress in detail. Tissue can be further processed using molecular analysis.
Ultimately, this model offers the possibility to optimize evaluation of strategies to improve anastomotic healing and treatment of its complications.
Supplementary information
Below is the link to the electronic supplementary material.
Acknowledgements
All authors have approved the manuscript. We thank Lucia Gampl for excellent technical assistance.
Author contribution
Study design: EM ZC SR MCW PAN; image acquisition: EM ZC VV RW; figure preparation: EM ZC MCW; writing and correcting the manuscript: EM ZC SR MCW RW VV HF PAN; funding acquisition HF PAN.
Funding
Open Access funding enabled and organized by Projekt DEAL. On the financial side, this work was made possible by support through grants from the Translational Medicine Program and Else Kröner-Fresenius-Stiftung (Technical University of Munich, Germany) and the Hanns-Seidel-Stiftung (Munich, Germany) to J.R.E. Miltschitzky; the Deutsche Forschungsgesellschaft (DFG) (Bonn, Germany) to P.-A. Neumann; the Kommission für Klinische Forschung (KKF) (Clinician scientist scholarship, Technical University of Munich, Germany) to S. Reischl and M.-C. Weber; Imperial-TUM Collaboration Fund (Imperial College London, UK) to N. Kamaly.
Declarations
Conflict of interest
The authors declare no competing interests.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
S. Reischl and P.-A. Neumann are contributed equally
J.R.E. Miltschitzky and Z. Clees ALSO contributed equally to each other.
References
- 1.Krarup PM, Nordholm-Carstensen A, Jorgensen LN, Harling H. Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: a nationwide cohort study. Ann Surg. 2014;259(5):930–938. doi: 10.1097/SLA.0b013e3182a6f2fc. [DOI] [PubMed] [Google Scholar]
- 2.Krarup PM, Jorgensen LN, Andreasen AH, Harling H, Danish Colorectal Cancer G. A nationwide study on anastomotic leakage after colonic cancer surgery. Colorectal Dis. 2012;14(10):e661–667. doi: 10.1111/j.1463-1318.2012.03079.x. [DOI] [PubMed] [Google Scholar]
- 3.Pommergaard HC, Gessler B, Burcharth J, Angenete E, Haglind E, Rosenberg J. Preoperative risk factors for anastomotic leakage after resection for colorectal cancer: a systematic review and meta-analysis. Colorectal Dis. 2014;16(9):662–671. doi: 10.1111/codi.12618. [DOI] [PubMed] [Google Scholar]
- 4.McDermott FD, Heeney A, Kelly ME, Steele RJ, Carlson GL, Winter DC. Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks. Br J Surg. 2015;102(5):462–479. doi: 10.1002/bjs.9697. [DOI] [PubMed] [Google Scholar]
- 5.Smith JA, King PM, Lane RH, Thompson MR. Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg. 2003;90(5):583–592. doi: 10.1002/bjs.4085. [DOI] [PubMed] [Google Scholar]
- 6.Matthiessen P, Hallbook O, Rutegard J, Simert G, Sjodahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007;246(2):207–214. doi: 10.1097/SLA.0b013e3180603024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Yauw ST, Wever KE, Hoesseini A, Ritskes-Hoitinga M, van Goor H. Systematic review of experimental studies on intestinal anastomosis. Br J Surg. 2015;102(7):726–734. doi: 10.1002/bjs.9776. [DOI] [PubMed] [Google Scholar]
- 8.Thornton FJ, Barbul A. Healing in the gastrointestinal tract. Surg Clin North Am. 1997;77(3):549–573. doi: 10.1016/S0039-6109(05)70568-5. [DOI] [PubMed] [Google Scholar]
- 9.Thompson SK, Chang EY, Jobe BA. Clinical review: healing in gastrointestinal anastomoses, part I. Microsurgery. 2006;26(3):131–136. doi: 10.1002/micr.20197. [DOI] [PubMed] [Google Scholar]
- 10.Goligher JC, Graham NG, De Dombal FT. Anastomotic dehiscence after anterior resection of rectum and sigmoid. Br J Surg. 1970;57(2):109–118. doi: 10.1002/bjs.1800570208. [DOI] [PubMed] [Google Scholar]
- 11.Sharefkin J, Joffe N, Silen W, Fromm D. Anastomotic dehiscence after low anterior resection of the rectum. Am J Surg. 1978;135(4):519–523. doi: 10.1016/0002-9610(78)90030-2. [DOI] [PubMed] [Google Scholar]
- 12.DiPietro LA. Wound healing: the role of the macrophage and other immune cells. Shock. 1995;4(4):233–240. doi: 10.1097/00024382-199510000-00001. [DOI] [PubMed] [Google Scholar]
- 13.Rijcken E, Sachs L, Fuchs T, Spiegel HU, Neumann PA. Growth factors and gastrointestinal anastomotic healing. J Surg Res. 2014;187(1):202–210. doi: 10.1016/j.jss.2013.10.013. [DOI] [PubMed] [Google Scholar]
- 14.Dubay DA, Franz MG. Acute wound healing: the biology of acute wound failure. Surg Clin North Am. 2003;83(3):463–481. doi: 10.1016/S0039-6109(02)00196-2. [DOI] [PubMed] [Google Scholar]
- 15.Nerstrom M, Krarup PM, Jorgensen LN, Agren MS. Therapeutic improvement of colonic anastomotic healing under complicated conditions: a systematic review. World J Gastrointest Surg. 2016;8(5):389–401. doi: 10.4240/wjgs.v8.i5.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, Neurath MF. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12(7):1295–1309. doi: 10.1038/nprot.2017.044. [DOI] [PubMed] [Google Scholar]
- 17.Neumann PA, Twardy V, Becker F, Geyer C, Schwegmann K, Mohr A, Faust A, Lenz P, Rijcken E. Assessment of MMP-2/-9 expression by fluorescence endoscopy for evaluation of anastomotic healing in a murine model of anastomotic leakage. PLoS One. 2018;13(3):e0194249. doi: 10.1371/journal.pone.0194249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Pommergaard HC, Rosenberg J, Schumacher-Petersen C, Achiam MP. Choosing the best animal species to mimic clinical colon anastomotic leakage in humans: a qualitative systematic review. Eur Surg Res. 2011;47(3):173–181. doi: 10.1159/000330748. [DOI] [PubMed] [Google Scholar]
- 19.Migaly J, Lieberman J, Long W, Fisher C, Rolandelli RH. Effect of adenoviral-mediated transfer of transforming growth factor-beta1 on colonic anastomotic healing. Dis Colon Rectum. 2004;47(10):1699–1705. doi: 10.1007/s10350-004-0647-3. [DOI] [PubMed] [Google Scholar]
- 20.Phillips JD, Kim CS, Fonkalsrud EW, Zeng H, Dindar H. Effects of chronic corticosteroids and vitamin A on the healing of intestinal anastomoses. Am J Surg. 1992;163(1):71–77. doi: 10.1016/0002-9610(92)90255-P. [DOI] [PubMed] [Google Scholar]
- 21.Fedakar-Senyucel M, Bingol-Kologlu M, Vargun R, Akbay C, Sarac FN, Renda N, Hasirci N, Gollu G, Dindar H. The effects of local and sustained release of fibroblast growth factor on wound healing in esophageal anastomoses. J Pediatr Surg. 2008;43(2):290–295. doi: 10.1016/j.jpedsurg.2007.10.016. [DOI] [PubMed] [Google Scholar]
- 22.Reischl S, Lee JH, Miltschitzky JRE, Vieregge V, Walter RL, Twardy V, Kasajima A, Friess H, Kamaly N, Neumann PA. Ac2-26-Nanoparticles induce resolution of intestinal inflammation and anastomotic healing via inhibition of NF-kappaB signaling in a model of perioperative colitis. Inflamm Bowel Dis. 2021 doi: 10.1093/ibd/izab008. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.